Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grillo

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Leukemia|April 18, 2002
Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophilsL E van der Kolk, M de Haas, A J Grillo-López, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activityJ C Byrd, C A White, B Link, et al.
Seminars in Oncology|February 28, 2001
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopeniaM N Saleh, J Gutheil, M Moore, et al.
Cancer Treatment Reports|March 1, 1986
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomasH S Greenberg, W D Ensminger, P B Layton, et al.
Circulation|June 15, 1999
Angiographic anatomy of the inferior right atrial isthmus in patients with and without history of common atrial flutterJ A Cabrera, D Sanchez-Quintana, S Y Ho, et al.
Cancer Research|November 15, 1988
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)J R Hardy, V J Harvey, J W Paxton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2aT A Davis, D G Maloney, A J Grillo-López, et al.
Cancer Treatment Reports|November 1, 1983
Phase I investigation of ametantroneD M Loesch, D D Von Hoff, J Kuhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphomaD G Maloney, A J Grillo-López, D J Bodkin, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Leukemia|April 18, 2002
Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophilsL E van der Kolk, M de Haas, A J Grillo-López, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activityJ C Byrd, C A White, B Link, et al.
Seminars in Oncology|February 28, 2001
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopeniaM N Saleh, J Gutheil, M Moore, et al.
Cancer Treatment Reports|March 1, 1986
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomasH S Greenberg, W D Ensminger, P B Layton, et al.
Circulation|June 15, 1999
Angiographic anatomy of the inferior right atrial isthmus in patients with and without history of common atrial flutterJ A Cabrera, D Sanchez-Quintana, S Y Ho, et al.
Cancer Research|November 15, 1988
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)J R Hardy, V J Harvey, J W Paxton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2aT A Davis, D G Maloney, A J Grillo-López, et al.
Cancer Treatment Reports|November 1, 1983
Phase I investigation of ametantroneD M Loesch, D D Von Hoff, J Kuhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphomaD G Maloney, A J Grillo-López, D J Bodkin, et al.
Pageof 9